|1.||Torsades de Pointes (Torsade de Pointes)
11/15/1996 - "The clinical observation of QT prolongation and torsade de pointes found with astemizole intake may principally be caused by the proarrhythmic effects of its metabolite desmethylastemizole."
11/15/1996 - "We report the clinical observation of QT prolongation and torsade de pointes in a patient with undetectable serum concentrations of astemizole (< 0.5 ng/ml) and "therapeutic" concentrations of desmethylastemizole (up to 7.7 ng/ml or 17.3 nmol/liter). "
11/15/1996 - "Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole."
|2.||Long QT Syndrome
|2.||Potassium Channels (Potassium Channel)